1
/
of
0
FDA Drug Approval, N012157, NORFLEX
FDA Drug Approval, N012157, NORFLEX
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 012157
Company: BAUSCH
Drug Name: NORFLEX
Active Ingredients: ORPHENADRINE CITRATE
Strength: 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 11/04/1959
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Company: BAUSCH
Drug Name: NORFLEX
Active Ingredients: ORPHENADRINE CITRATE
Strength: 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: TABLET, EXTENDED RELEASE;ORAL
Action Date: 11/04/1959
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details